Question
Will the combination of semaglutide and cagrilintide be approved for the treatment of obesity by the FDA or EMA by 2027?
Total Forecasters25
Community Prediction43%
Make a Prediction
median 43.0%mean 41.4%
Authors:
Opened:
Closes:
Scheduled resolution:
Comments
? comments
Authors:
Opened:
Closes:
Scheduled resolution:
